Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer

We report on the efficacy and toxicity of a sequential high-dose therapy with peripheral blood stem cell (PBSC) support in 85 patients with high-risk stage II/III breast cancer. There were 71 patients with more than nine tumour-positive axillary lymph nodes. An induction therapy of two cycles of ifo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohaus, S, Funk, L, Martin, S, Schlenk, R F, Abdallah, A, Hahn, U, Egerer, G, Goldschmidt, H, Schneeweiß, A, Fersis, N, Kaul, S, Wallwiener, D, Bastert, G, Haas, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362726/
https://www.ncbi.nlm.nih.gov/pubmed/10188897
http://dx.doi.org/10.1038/sj.bjc.6690239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362726/
https://www.ncbi.nlm.nih.gov/pubmed/10188897
http://dx.doi.org/10.1038/sj.bjc.6690239

Ejemplares similares